Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone

This trial compares two treatments for reducing eye pressure in people with glaucoma or ocular hypertension (elevated eye pressure that can damage vision). It tests adding a travoprost intraocular implant (a tiny drug-releasing device placed in the eye) to a procedure called iStent Infinite, versus iStent Infinite alone. **You may be eligible if...** - You have been diagnosed with open-angle glaucoma or ocular hypertension - Your eye pressure qualifies for the study based on screening measurements **You may NOT be eligible if...** - Your unmedicated eye pressure exceeds 36 mmHg - You are allergic to travoprost or any components of the implant - You have a severe visual field loss or a large optic nerve cup-to-disc ratio (>0.8) - Your best corrected vision is worse than 20/80 in either eye - You have another eye disease that could interfere with the study Talk to your doctor to see if this trial is right for you.